Chronic hepatitis B with insomnia
Conditions
Interventions
Treatment group:Basic treatment of chronic hepatitis B+oryzanol+Baduanjin
Control group:Basic treatment of chronic hepatitis B+oryzanol
Sponsors
Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Aged 18 to 70 years (male or female); 2.Insomnia diagnosed in accordance with the 2017 Edition of Chinese Guidelines for The Diagnosis and Treatment of Insomnia; 3.PSQI score > 5; 4.Chronic hepatitis B diagnosed according to the 2019 Edition of the Guidelines for the Prevention and Treatment of chronic hepatitis B; 5.Participate voluntarily and sign the informed consent form; 6.Have not taken sedative and tranquilizer drugs or long-term use of sedative and tranquilizer drugs is ineffective and the drug has been stopped for more than 2 months.
Exclusion criteria
Exclusion criteria: 1.Patients who have superinfections such as hepatitis A and C; 2.Patients who have liver cirrhosis, liver cancer, and those who are in critical condition; 4.Patients who have muscle and bone diseases are not suitable for Baduanjin practice; 5.Patients with severe respiratory, circulatory, and nervous system diseases; 6.Insomnia caused by other organic diseases or taking psychotropic drugs; 7.Participating or planning to participate in other exercise programs (such as Tai Chi or Wu Qin Xi).
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Self-rating anxiety scale;Hamilton rating scale for depression; | — |
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index Scale;Insomnia Severity Index Scale; | — |
Countries
China
Contacts
Public ContactHu Xiaoyu
Clinical School of Medicine, Chengdu University of Traditional Chinese Medicine
Outcome results
None listed